Showing results (411-420 of 592) with videos related to

Sort By:
Pageof 60
Frontiers in Oncology|September 26, 2022
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approachAlessandra Fabi, Giuseppe Buono, Emilio Bria, et al.
Plos One|November 16, 2013
Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panelAldo Scarpa, Katarzyna Sikora, Matteo Fassan, et al.
Clinical Breast Cancer|March 28, 2025
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective StudyGiovanna Garufi, Luca Mastrantoni, Noemi Maliziola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2023
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized TrialPierFranco Conte, Giancarlo Bisagni, Federico Piacentini, et al.
Cytokine & Growth Factor Reviews|February 21, 2021
Anticancer innovative therapy congress: Highlights from the 10th anniversary editionFrancesca De Santis, Giovanni Fucà, Dirk Schadendorf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR+, HER2--Advanced Breast CancerPatrick Neven, Stephen R D Johnston, Masakazu Toi, et al.
Pathology|September 5, 2014
Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinomaFrancesco Massari, Chiara Ciccarese, Antonio Bentito Porcaro, et al.
Scientific Reports|May 10, 2018
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinomaMichele Simbolo, Caterina Vicentini, Andrea Ruzzenente, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 26, 2013
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancersMatteo Fassan, Michele Simbolo, Emilio Bria, et al.
Breast Cancer Research and Treatment|October 20, 2024
Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical recordsPaul Cottu, Sue Cheeseman, Peter Hall, et al.
Pageof 60